HUINNO Co., Ltd clinical trials
The registry lists 11 studies whose lead sponsor is HUINNO Co., Ltd or one of 1 company grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 28, 2026.
Our grouping of 2 registry names, not the registry’s. See them and correct one ↓
- 11studies on the registry
- 3open to participants now
- 2reach primary completion within a year
Get an email when these change. Save the HUINNO Co., Ltd studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Coming up
2 of HUINNO Co., Ltd’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- 2NNov ’26’26
- DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- SSep
- OOct
- NNov
All 2
Add all 2 to your calendar (.ics) → With an account.
All 11 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Where
- Korea, Republic of9
Over the years
- 20
- 21
- 22
- 23
- 24
- 425
- 226
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to HUINNO Co., Ltd.
- HUINNO Co., Ltd8 studiesSame company
Something wrong?
- Huinno AIM3 studies →Subsidiary
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 11 of 11.
- Clinical Validation of SMD-AFECG for Predicting New-Onset Atrial Fibrillation Within 2 Hours Using Single-Lead ECG DataNot yet recruitingNCT07722078
- Clinical Validation of SMD-RVECG for Predicting Atrial Fibrillation With Rapid Ventricular Response Within 2 HoursNot yet recruitingNCT07722039
- Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation TherapyNot yet recruitingNCT06751459Not applicable
- Arrhythmia Detection With MEMO Patch Plus in Patients With Acute Heart FailureCompletedNCT07792772Not applicable
- Clinical Validation of Vital-PICASO for Predicting Hypoxia Within 24 Hours in General Ward InpatientsCompletedNCT07742813
Sponsor listed in the registry: Huinno AIM
- Clinical Validation of Vital-PICASO for Predicting Hypotension Within 24 Hours in General Ward InpatientsCompletedNCT07742930
Sponsor listed in the registry: Huinno AIM
- Clinical Validation of Vital-PICASO for Predicting Cardiac Arrest Within 24 HoursCompletedNCT07742943
Sponsor listed in the registry: Huinno AIM
- Remote ECG Monitoring-Based Phase I Cardiac Rehabilitation After Heart SurgeryCompletedNCT07736066Not applicable
- 7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With PalpitationsCompletedNCT07728552Not applicable
- Evaluation of an AI-Based Lightweight ECG Telemetry Monitoring SystemCompletedNCT07725445Not applicable
- This Exploratory Medical Device Study Evaluated the Arrhythmia Diagnostic Yield of MEMO Patch V2, a Wearable Patch-type Electrocardiographic Monitor, in Adults With Suspected Arrhythmia Who Presented With Symptoms Such as Palpitations or Dizziness, or Who Had Cryptogenic Ischemic Stroke or TransientCompletedNCT07722026Not applicable